Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

Baylor College of Medicine: Houston, TX, US

1999-06-01 to present | Professor (Medicine)
Employment
Source: Self-asserted source
Farrah Kheradmand

Education and qualifications (1)

George Washington University: Washington, DC, US

1984-06-01 to 1989-06-30 | MD (Medicine)
Education
Source: Self-asserted source
Farrah Kheradmand

Funding (10)

Enhancement of Immune Memory Responses to Respiratory Infection

2016-08-01 to 2019-07-31 | Grant
United States Army (Washington, US)
URL: https://grants.uberresearch.com/100006751/W81XWH1610361/Enhancement-of-Immune-Memory-Responses-to-Respiratory-Infection
GRANT_NUMBER:

W81XWH1610361
Source: Self-asserted source
Farrah Kheradmand via DimensionsWizard
grade
Preferred source (of 2)‎

Th1 and Th17 Mediators in Experimental Emphysema

2013-08-01 to 2017-06-30 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
URL: https://grants.uberresearch.com/100000050/R01HL117181/Th1-and-Th17-Mediators-in-Experimental-Emphysema
GRANT_NUMBER: R01HL117181
Source: Self-asserted source
Farrah Kheradmand via DimensionsWizard

Ancillary T Cell Based Studies in SPIROMICS

2012-02-15 to 2017-01-31 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
URL: https://grants.uberresearch.com/100000050/R01HL110883/Ancillary-T-Cell-Based-Studies-in-SPIROMICS
GRANT_NUMBER: R01HL110883
Source: Self-asserted source
Farrah Kheradmand via DimensionsWizard

Regulation of Innate and Acquired Immunity in Human COPD and Emphysema

2009-04-01 to 2018-06-30 | Grant
U.S. Department of Veterans Affairs (Washington, US)
URL: https://grants.uberresearch.com/100000738/I01CX000104/Regulation-of-Innate-and-Acquired-Immunity-in-Human-COPD-and-Emphysema
GRANT_NUMBER: I01CX000104
Source: Self-asserted source
Farrah Kheradmand via DimensionsWizard

Molecular Phenotypes for Lung Diseases

2008-09-24 to 2012-07-31 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
URL: https://grants.uberresearch.com/100000050/R01HL095382/Molecular-Phenotypes-for-Lung-Diseases
GRANT_NUMBER: R01HL095382
Source: Self-asserted source
Farrah Kheradmand via DimensionsWizard

Viral-induced T Cell Responses in COPD Exacerbation

2005-09-15 to 2012-07-31 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
URL: https://grants.uberresearch.com/100000050/R01HL082487/Viral-induced-T-Cell-Responses-in-COPD-Exacerbation
GRANT_NUMBER: R01HL082487
Source: Self-asserted source
Farrah Kheradmand via DimensionsWizard

The Role of Proteases in Lung Inflammation &Remodeling

2003-05-08 to 2008-04-30 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
URL: https://grants.uberresearch.com/100000050/K02HL072062/The-Role-of-Proteases-in-Lung-Inflammation-Remodeling
GRANT_NUMBER: K02HL072062
Source: Self-asserted source
Farrah Kheradmand via DimensionsWizard

Immune modulators of inflammation in servere COPD

2002-07-01 to 2012-06-30 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
URL: https://grants.uberresearch.com/100000050/R01HL072419/Immune-modulators-of-inflammation-in-servere-COPD
GRANT_NUMBER: R01HL072419
Source: Self-asserted source
Farrah Kheradmand via DimensionsWizard

The Role of Proteinases in Experimental Asthma

1999-09-30 to 2006-07-14 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
URL: https://grants.uberresearch.com/100000050/R01HL064061/The-Role-of-Proteinases-in-Experimental-Asthma
GRANT_NUMBER: R01HL064061
Source: Self-asserted source
Farrah Kheradmand via DimensionsWizard

EPITHELIAL/MESENCHYMAL INTERACTIONS IN LUNG DEVELOPMENT

1997-09-01 to 2003-12-31 | Grant
National Heart, Lung, and Blood Institute (Bethesda, US)
URL: https://grants.uberresearch.com/100000050/K08HL003732/EPITHELIAL-MESENCHYMAL-INTERACTIONS-IN-LUNG-DEVELOPMENT
GRANT_NUMBER: K08HL003732
Source: Self-asserted source
Farrah Kheradmand via DimensionsWizard

Works (9)

Sialidase fusion protein protects against influenza infection in a cigarette smoke-induced model of COPD

Mucosal Immunology
2025-04 | Journal article
DOI: 10.1016/j.mucimm.2025.01.004
Contributors: Cheng-Yen Chang; Dominique Armstrong; John M. Knight; Trevor V. Gale; Stephen Hawley; Max Wang; Nancy Chang; David B. Corry; Farrah Kheradmand
Source: check_circle
Crossref

MAGE-A4 Induces Non-Small Cell Lung Cancer and Tumor-Promoting Plasma Cell Accumulation

Science Advances
2025-02-12 | Journal article | Author
DOI: 10.1126/sciadv.ads4227
Contributors: Briana Burns; Cheng-Yen Chang; Lizhen Song; Kelsey Mauk; William Hudson; Xiang Zhang; Chad Creighton; Monica Hong; Benjamin Casal; Neil McKenna et al.
Source: check_circle
AAAS - Science

Contribution of adaptive immunity to human COPD and experimental models of emphysema

Physiological Reviews
2023-04-01 | Journal article
DOI: 10.1152/physrev.00036.2021
Contributors: Farrah Kheradmand; Yun Zhang; David B. Corry
Source: check_circle
Crossref

Innate immune cell dysfunction and systemic inflammation in children with chronic liver diseases undergoing transplantation

American Journal of Transplantation
2023-01 | Journal article
DOI: 10.1016/j.ajt.2022.09.004
Contributors: Krupa R. Mysore; Sunil Kannanganat; Jeremy M. Schraw; Philip J. Lupo; John A. Goss; Kenneth D.R. Setchell; Farrah Kheradmand; Xian C. Li; Benjamin L. Shneider
Source: check_circle
Crossref

Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft

JCI Insight
2021-07-08 | Journal article
DOI: 10.1172/jci.insight.140116
Contributors: Duy Tri Le; Tridu R. Huynh; Bryan Burt; George Van Buren; Shawn A. Abeynaike; Cristina Zalfa; Rana Nikzad; Farrah Kheradmand; John J. Tyner; Silke Paust
Source: check_circle
Crossref

NK cells and CTLs are required to clear solid tumor in a novel model of patient-derived-xenograft

2020-05-26 | Preprint
DOI: 10.1101/2020.05.24.112722
Contributors: Duy Tri Le; Bryan Burt; George Van Buren; Shawn Abeynaike; Cristina Zalfa; Rana Nikzad; Farrah Kheradmand; Silke Paust
Source: check_circle
Crossref

Taming Peptides with Peptides: Neutralizing Proline-Glycine-Proline with l-Arginine-Threonine-Arginine to Treat Cigarette Smoke–induced Emphysema

American Journal of Respiratory Cell and Molecular Biology
2019-11 | Journal article
DOI: 10.1165/rcmb.2019-0145ED
Contributors: Matthew C. Madison; Farrah Kheradmand
Source: check_circle
Crossref

Loss of Peripheral Tolerance in Emphysema. Phenotypes, Exacerbations, and Disease Progression

Annals of the American Thoracic Society
2015-11 | Journal article
DOI: 10.1513/AnnalsATS.201503-115AW
Contributors: Sivasubramanium Bhavani; Xiaoyi Yuan; Ran You; Ming Shan; David Corry; Farrah Kheradmand
Source: check_circle
Crossref

Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD)

American Journal of Respiratory and Critical Care Medicine
2015-11-15 | Journal article
DOI: 10.1164/rccm.201504-0736OC
Contributors: Sivasubramanium Bhavani; Chu-Lin Tsai; Sarah Perusich; Sean Hesselbacher; Harvey Coxson; Lavannya Pandit; David B. Corry; Farrah Kheradmand
Source: check_circle
Crossref
How many people are using ORCID?